Skip to main content
logo
Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.150
-0.040 (-3.36%)
Aug 28, 2026, 3:28 PM EDT - Market open

Milestone Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-84.01-63.06-41.52-59.69-58.39-42.85
Depreciation & Amortization
0.750.70.650.60.480.36
Other Amortization
0.460.430.370.24--
Loss (Gain) From Sale of Assets
--0.01-0.14-
Loss (Gain) From Sale of Investments
--0.08-0.45-0.16-0.1-
Stock-Based Compensation
7.427.465.789.539.057.28
Other Operating Activities
9.772.832.671.8-0.39-0.27
Change in Accounts Receivable
-2.88-0.161.72-2.33-0.760.1
Change in Inventory
-4.72-0.65----
Change in Accounts Payable
6.254.430.881.04-0.910.64
Change in Other Net Operating Assets
4.64-0.941.062.53-1.61.52
Operating Cash Flow
-61.29-49.04-28.85-46.42-52.47-33.22
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.36-0.3-0.03-0.11-0.27-
Investment in Securities
0.0411.558.324.87-56.8570
Investing Cash Flow
-0.3211.258.284.76-57.1270

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---50--
Net Debt Issued (Repaid)
74.98--50--
Issuance of Common Stock
111.2982.9527.50.583.090.12
Other Financing Activities
2.572.574.62-2.79-4.93
Financing Cash Flow
188.8485.5332.1247.793.095.06

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
127.2347.7311.556.12-106.5141.83

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-61.65-49.34-28.88-46.54-52.74-33.22
Free Cash Flow Growth
------
Free Cash Flow Margin
-2631.07%-3191.66%--4653.60%-1054.82%-221.49%
Free Cash Flow Per Share
-0.52-0.59-0.46-1.08-1.24-0.79
Levered Free Cash Flow
-41.69-28.9-18.12-28.29-31.36-17.05
Unlevered Free Cash Flow
-35.39-26.94-16.25-26.94-31.36-17.05

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
4.322.683.661.24-3.262.26
SEC Filings: 10-K · 10-Q